Drugs / Fecal Microbiota Transplantation Capsule
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06026371 | Dec 2023 → Sep 2026 overdue | acute graft versus host disease, hematopoietic and lymphoid system neoplasm | Fred Hutchinson Cancer Center | Active not recruiting | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fecal Microbiota Transplantation Capsule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06026371 ↗ |
| Action | Restore | “FMT is a holistic microbiota restoration approach that can be performed as a precision therapeutic.” PMID 39863610 ↗ Jan 2025 |
| Route | Oral | “Given PO” NCT06026371 ↗ |